KR101762460B1 - 내산성 캡슐 - Google Patents

내산성 캡슐 Download PDF

Info

Publication number
KR101762460B1
KR101762460B1 KR1020127010224A KR20127010224A KR101762460B1 KR 101762460 B1 KR101762460 B1 KR 101762460B1 KR 1020127010224 A KR1020127010224 A KR 1020127010224A KR 20127010224 A KR20127010224 A KR 20127010224A KR 101762460 B1 KR101762460 B1 KR 101762460B1
Authority
KR
South Korea
Prior art keywords
soluble film
forming polymer
water
gellan gum
film forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127010224A
Other languages
English (en)
Korean (ko)
Other versions
KR20120079836A (ko
Inventor
도미니크 니콜라스 케이드
싱그웨이 데이비드 아슈어
Original Assignee
캡슈겔 벨지엄 엔브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 캡슈겔 벨지엄 엔브이 filed Critical 캡슈겔 벨지엄 엔브이
Publication of KR20120079836A publication Critical patent/KR20120079836A/ko
Application granted granted Critical
Publication of KR101762460B1 publication Critical patent/KR101762460B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/003—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14—Dipping a core
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D22/00—Producing hollow articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2001/00—Use of cellulose, modified cellulose or cellulose derivatives, e.g. viscose, as moulding material
    • B29K2001/08—Cellulose derivatives
    • B29K2001/12—Cellulose acetate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2003/00—Use of starch or derivatives as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2005/00—Use of polysaccharides or derivatives as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2089/00—Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/712—Containers; Packaging elements or accessories, Packages
    • B29L2031/7174—Capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020127010224A 2009-09-24 2010-09-14 내산성 캡슐 Active KR101762460B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24539209P 2009-09-24 2009-09-24
US61/245,392 2009-09-24
PCT/IB2010/054131 WO2011036601A1 (en) 2009-09-24 2010-09-14 Acid resistant capsules

Publications (2)

Publication Number Publication Date
KR20120079836A KR20120079836A (ko) 2012-07-13
KR101762460B1 true KR101762460B1 (ko) 2017-07-27

Family

ID=43027570

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127010224A Active KR101762460B1 (ko) 2009-09-24 2010-09-14 내산성 캡슐

Country Status (16)

Country Link
US (4) US8852631B2 (enExample)
EP (1) EP2480218B1 (enExample)
JP (1) JP5777625B2 (enExample)
KR (1) KR101762460B1 (enExample)
CN (1) CN102665697B (enExample)
AU (1) AU2010299527A1 (enExample)
BR (1) BR112012006651B1 (enExample)
CA (1) CA2775227C (enExample)
CO (1) CO6531471A2 (enExample)
DK (1) DK2480218T3 (enExample)
ES (1) ES2804779T3 (enExample)
MX (1) MX2012003540A (enExample)
PL (1) PL2480218T3 (enExample)
RU (1) RU2012116362A (enExample)
TW (1) TW201127370A (enExample)
WO (1) WO2011036601A1 (enExample)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012006651B1 (pt) 2009-09-24 2021-11-03 Capsugel Belgium Nv Cápsula farmacêutica dura resistente a ácido e composição aquosa compreendendo goma de gelano e hpmc
EP2776016B1 (en) 2011-11-09 2019-02-20 Capsugel Belgium NV Acid resistant banding solution for acid resistant two piece hard capsules
JP6397813B2 (ja) 2012-05-02 2018-09-26 キャプシュゲル・ベルジウム・エヌ・ヴィ ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液
ES2879892T3 (es) * 2012-05-21 2021-11-23 Capsugel Belgium Nv Uso de una solución banda resistente a los ácidos para sellar cápsulas duras de dos piezas
WO2013174884A1 (en) 2012-05-23 2013-11-28 Capsugel France SAS Capsules having an incorporated taste modifying component
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
JP6133702B2 (ja) * 2013-06-18 2017-05-24 紀州技研工業株式会社 インクジェットインキ、その製造方法及びその使用方法
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
JP6060102B2 (ja) * 2014-03-13 2017-01-11 紀州技研工業株式会社 インクジェットインク及びその作製方法並びにインクジェットインクを用いた印字方法
CN103893772B (zh) 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种羟丙基淀粉空心胶囊及其制备工艺
CN103937038B (zh) * 2014-04-28 2016-08-17 中国科学院化学研究所 用于制备空心胶囊的组合物及其淀粉基质空心胶囊
JP6297441B2 (ja) * 2014-07-31 2018-03-20 森永乳業株式会社 ビフィドバクテリウム属細菌含有カプセルおよびその製造方法
EP3181125B1 (en) * 2014-07-31 2025-02-19 Capsugel Belgium NV Capsule formulation
EP3028694B1 (en) 2014-12-02 2017-07-12 Capsugel Belgium NV Dosage form articles for delayed release
US9744221B2 (en) 2014-12-23 2017-08-29 Synthetic Biologics, Inc. Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
US20160199433A1 (en) * 2015-01-13 2016-07-14 New Chapter, Inc. Vegetarian Capsules Containing Supercritical Herbal Extracts
EP3167880B1 (en) 2015-11-10 2019-06-19 Capsugel Belgium NV Acid resistant banding or sealing solution for acid resistant two piece hard capsules
US20170157058A1 (en) * 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
EP3246000A1 (en) 2016-05-18 2017-11-22 Capsugel Belgium NV Separable capsule for sprinkling applications
EP3272340A1 (en) 2016-07-22 2018-01-24 Capsugel Belgium NV Acid resistant capsules
IL311081A (en) 2016-08-24 2024-04-01 Prilenia Neurotherapeutics Ltd Use of pyridofidine to treat functional decline
JP2018199631A (ja) * 2017-05-26 2018-12-20 株式会社ファンケル ビフィズス菌含有カプセル製剤
EP3653203A4 (en) 2017-07-11 2020-06-24 Qualicaps Co., Ltd. ENTERAL HARD CAPSULE
CO2017007322A1 (es) * 2017-07-24 2019-01-31 Novamed S A Cápsulas duras resistentes al ácido con bajo contenido de coadyuvantes de gelificacion
KR20200038506A (ko) 2017-08-07 2020-04-13 핀치 테라퓨틱스, 인코포레이티드 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
US11083738B2 (en) 2017-09-28 2021-08-10 Natals, Inc. Dietary nutrient compositions
AU2019207600B2 (en) 2018-01-09 2025-01-09 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
WO2019165285A1 (en) 2018-02-23 2019-08-29 Crestovo Holdings Llc Microbiome related immunotherapies
EP4275761A3 (en) 2018-03-20 2024-02-28 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
EP3768302B1 (en) 2018-03-20 2025-05-07 Theriva Biologics, Inc. Intestinal alkaline phosphatase formulations
WO2019178698A1 (en) * 2018-03-21 2019-09-26 Ryan Selby Vaporizer capsules and methods of manufacture
EP3549578A1 (en) * 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
KR20210022716A (ko) 2018-06-22 2021-03-03 쿠오리카프스 가부시키가이샤 장용성 경질 캡슐
EP3632449A1 (en) 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
EP3650011A1 (en) 2018-11-09 2020-05-13 Bio Minerals NV Water soluble silicon-containing granulate
KR102182326B1 (ko) 2019-02-19 2020-11-24 주식회사 서흥 내산성 셀룰로오스 캡슐의 제조방법
JP7504905B2 (ja) * 2019-03-14 2024-06-24 エボニック オペレーションズ ゲーエムベーハー コア－シェルポリマーとセルロースとを含むカプセルシェル
ES3024384T3 (en) 2019-07-18 2025-06-04 Theriva Biologics Inc Intestinal alkaline phosphatase-based treatments of metabolic disorders
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
CN114650833A (zh) 2019-09-13 2022-06-21 芬奇治疗控股有限责任公司 用于治疗孤独症谱群障碍的组合物和方法
MX2022004515A (es) * 2019-10-16 2022-07-12 Capsugel Belgium Nv Metodo y composicion para aumentar la sintesis de proteinas musculares.
EP4027990A4 (en) * 2019-10-16 2023-10-18 Capsugel Belgium NV METHOD AND COMPOSITION FOR INCREASE SYNTHESIS OF MUSCLE PROTEIN
CA3158132A1 (en) 2019-10-18 2021-04-22 Finch Therapeutics Holdings Llc Compositions and methods for delivering a bacterial metabolite to a subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021202806A1 (en) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
CA3181945A1 (en) * 2020-05-31 2021-12-09 Eirgen Pharma Ltd. Hard capsule dosage form and uses thereof
US20240010678A1 (en) * 2020-09-08 2024-01-11 The Johns Hopkins University Method of treatment of irritable bowel syndrome
WO2022112422A1 (en) * 2020-11-25 2022-06-02 Capsugel France SAS Double layered delayed-release hard capsules
JP7719609B2 (ja) * 2021-02-12 2025-08-06 クオリカプス株式会社 腸溶性硬質カプセル
WO2022178294A1 (en) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject
WO2022244713A1 (ja) * 2021-05-18 2022-11-24 ロンザ株式会社 非ゼラチン硬カプセル及びその製造方法
US20240285699A1 (en) * 2021-06-24 2024-08-29 Lonza Greenwood Llc Method to Control Administration of Active Substance to the Digestive Tract
JPWO2023100643A1 (enExample) 2021-11-30 2023-06-08
CN118340904B (zh) * 2024-04-19 2025-04-15 山东赫尔希胶囊有限公司 一种羟丙甲纤维素成膜组合物及其应用
TWI920707B (zh) * 2024-09-04 2026-04-01 星歐光學股份有限公司 抗酸膠囊殼及抗酸膠囊

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165775A1 (en) * 2002-10-22 2006-07-27 Eastgate Investments Limited Capsule and film-forming composition comprising gum arabic

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144225A (en) 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers
US4756902A (en) 1986-06-02 1988-07-12 Warner-Lambert Company Capsule sealing process and product
US5006346A (en) 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5264223A (en) 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JP3116602B2 (ja) 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 硬質カプセル
US5431917A (en) 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JPH07196478A (ja) 1993-12-30 1995-08-01 Hajime Sugii 安全性の高い食品及び医薬品用ソフトカプセル
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
JP4249816B2 (ja) 1997-02-24 2009-04-08 富士カプセル株式会社 ソフトカプセル
US6326028B1 (en) 1997-10-31 2001-12-04 Monsanto Company Alginate and gellan gum as tablet coating
JP3449253B2 (ja) 1998-10-29 2003-09-22 シオノギクオリカプス株式会社 硬質カプセルの製造方法
DE19926714A1 (de) * 1999-01-25 2000-08-10 Su Heung Capsule Co Pflanzliche Steckkapseln und Verfahren für deren Herstellung
JP3716901B2 (ja) 1999-04-14 2005-11-16 シオノギクオリカプス株式会社 セルロースエーテルフィルム
US6294008B1 (en) 1999-04-21 2001-09-25 The Dow Chemical Company Haze-free cellulose ether capsules and process for making
CN1252154C (zh) 1999-07-22 2006-04-19 沃纳-兰伯特公司 支链淀粉膜组合物
KR100379674B1 (ko) 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
GB2366780A (en) 2000-07-07 2002-03-20 Bioprogress Tech Int Inc Foam capsules
EP1184033A1 (en) 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
JP2002145783A (ja) 2000-11-06 2002-05-22 Kohjin Co Ltd Ｓ−アデノシルメチオニンまたはその塩類を含有するカプセル製剤
US20030072731A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
GB0221986D0 (en) 2002-09-21 2002-10-30 Bioprogress Technology Ltd Films with improved barrier properties
TW200520790A (en) 2003-12-22 2005-07-01 Dah Feng Capsule Industry Co Ltd The compositions of a vegetarian capsule shell
JPWO2005113010A1 (ja) 2004-05-24 2008-07-31 クオリカプス株式会社 表面改質および溶解性が改善された硬カプセル
WO2006043284A1 (en) 2004-10-21 2006-04-27 Sunil Mundra A process for manufacturing neutraceutical, pharmaceutical cellulose derivatives capsule
EP1832282A1 (en) 2004-12-28 2007-09-12 Qualicaps Co., Ltd. Band seal for hard capsule
KR100661336B1 (ko) 2005-02-21 2006-12-27 주식회사 서흥캅셀 기계적 피막강도를 향상시킨 셀룰로오스 경질캅셀
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
US20070043284A1 (en) 2005-08-16 2007-02-22 Robert Sanfilippo Medical electrode and method of use
EP1762232A1 (en) 2005-09-09 2007-03-14 Warner-Lambert Company LLC Liquid filled delivery system, preferably an HPMC capsule filled with glycerol
US20100233252A1 (en) 2006-01-24 2010-09-16 Qualicaps Co., Ltd. Low-Moisture-Content Hard Capsule and Production Method Therefor
WO2007098612A1 (en) 2006-03-02 2007-09-07 Laboratoires Mauves Inc. Gastric acid resistant gelatin capsule composition and method for producing same
MX2009000145A (es) * 2006-06-30 2009-01-23 Mcneil Ppc Inc Capsulas duras llenas con liquido que contiene ibuprofeno.
CA2667167C (en) 2006-10-27 2014-02-18 Pfizer Products Inc. Hydroxypropyl methyl cellulose hard capsules and process of manufacture
GB0706178D0 (en) 2007-03-29 2007-05-09 Univ Aston Enteric pharmaceutical capsules
WO2009021377A1 (en) * 2007-08-10 2009-02-19 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin shell material of hard capsule and process for preparing thereof
WO2009062356A1 (en) 2007-11-13 2009-05-22 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin enteric hard capsule shell and preparation method thereof
JP5178236B2 (ja) * 2008-02-25 2013-04-10 クオリカプス株式会社 腸溶性カプセル
US8825387B2 (en) 2008-07-25 2014-09-02 Navteq B.V. Positioning open area maps
JP5253235B2 (ja) * 2009-03-02 2013-07-31 クオリカプス株式会社 腸溶性カプセル
EP2496219A1 (en) 2009-06-29 2012-09-12 McNeil-PPC, Inc. Pharmaceutical tablet containing a liquid filled capsule
CA2772144A1 (en) 2009-09-04 2011-03-10 Dominique Nicolas Cade Scented capsules
BR112012006651B1 (pt) 2009-09-24 2021-11-03 Capsugel Belgium Nv Cápsula farmacêutica dura resistente a ácido e composição aquosa compreendendo goma de gelano e hpmc
US20140227357A1 (en) 2011-09-14 2014-08-14 Capsugel Belgium Nv Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
JP2014172850A (ja) 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
EP3181125B1 (en) 2014-07-31 2025-02-19 Capsugel Belgium NV Capsule formulation
WO2016099921A1 (en) 2014-12-16 2016-06-23 E. I. Du Pont De Nemours And Company Films, fluoropolymer coated films and highly cleanable articles
TWI587880B (zh) 2015-03-24 2017-06-21 Can be made into the composition of enteric capsule shell, enteric capsule shell and its process
US9452141B1 (en) 2015-05-01 2016-09-27 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
US20170157058A1 (en) 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165775A1 (en) * 2002-10-22 2006-07-27 Eastgate Investments Limited Capsule and film-forming composition comprising gum arabic

Also Published As

Publication number Publication date
US10874619B2 (en) 2020-12-29
US20150050334A1 (en) 2015-02-19
US20170231918A1 (en) 2017-08-17
ES2804779T3 (es) 2021-02-09
EP2480218B1 (en) 2020-05-27
US10231934B2 (en) 2019-03-19
US20190175514A1 (en) 2019-06-13
RU2012116362A (ru) 2013-10-27
WO2011036601A1 (en) 2011-03-31
AU2010299527A1 (en) 2012-04-19
CN102665697A (zh) 2012-09-12
CA2775227A1 (en) 2011-03-31
PL2480218T3 (pl) 2020-11-16
CA2775227C (en) 2017-12-19
TW201127370A (en) 2011-08-16
CO6531471A2 (es) 2012-09-28
JP5777625B2 (ja) 2015-09-09
EP2480218A1 (en) 2012-08-01
CN102665697B (zh) 2014-07-09
KR20120079836A (ko) 2012-07-13
US20120288562A1 (en) 2012-11-15
MX2012003540A (es) 2012-09-07
JP2013505928A (ja) 2013-02-21
BR112012006651A2 (pt) 2020-08-11
BR112012006651B1 (pt) 2021-11-03
US9700517B2 (en) 2017-07-11
US8852631B2 (en) 2014-10-07
DK2480218T3 (da) 2020-08-24

Similar Documents

Publication Publication Date Title
US10874619B2 (en) Acid resistant capsules
AU762692C (en) Modified starch film compositions
JP4065691B2 (ja) プルラン膜組成物
JP6626712B2 (ja) 放出制御ポリマーの水性分散液並びにそのシェル及びカプセル
KR101900966B1 (ko) 벌크한 장용성 캡슐 쉘
JP2011500871A (ja) ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
JP2004507581A (ja) ペクチンフィルム組成物
EP1593376A1 (en) Improved pullulan capsules
EP1072633A1 (en) Pullulan film compositions
JP7719609B2 (ja) 腸溶性硬質カプセル
MXPA02000739A (en) Pullulan film compositions

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20200624

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20210625

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20220711

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 9